Acta Neuropathol
- FARRELL C, Buhidma Y, Mumford P, Heywood WE, et al
Apolipoprotein E abundance is elevated in the brains of individuals with Down
syndrome-Alzheimer's disease.
Acta Neuropathol. 2025;149:49.
- BRAAK H, Mayer B, Feldengut S, Schon M, et al
Sequence and trajectory of early Alzheimer's disease-related tau inclusions in
the hippocampal formation of cases without amyloid-beta deposits.
Acta Neuropathol. 2025;149:50.
Alzheimer Dis Assoc Disord
- CAYIR S, Sadabad FE, Mecca AP, Matuskey D, et al
Cerebrospinal Fluid Biomarkers and Cognition in Alzheimer Disease and
Frontotemporal Dementia in a Memory Clinic Setting.
Alzheimer Dis Assoc Disord. 2025;39:22-27.
Alzheimers Dement
- WYMAN-CHICK KA, Ferman TJ, Armstrong MJ, Chrenka EAB, et al
Sex differences in prodromal dementia with Lewy bodies using the National
Alzheimer's Coordinating Center data.
Alzheimers Dement. 2025;21:e70275.
- LIU DX, Braskie MN, Cavailles C, Peltz C, et al
Sleep macro-architecture, nocturnal hypoxemia, and Alzheimer's disease-related
MRI patterns among diverse older adults.
Alzheimers Dement. 2025;21:e70280.
- PRYNN JE, Walsh S
Reply to: Investing in equitable healthy aging: Why Africa must reform social
pension schemes to improve Alzheimer's disease and dementia outcomes.
Alzheimers Dement. 2025;21:e70298.
- SALLOWAY S, Pain A, Lee E, Papka M, et al
TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid
plaque clearance in early, symptomatic Alzheimer's disease.
Alzheimers Dement. 2025;21:e70293.
- XU X, Yang X, Zhang J, Wang Y, et al
Choroid plexus free-water correlates with glymphatic function in Alzheimer's
disease.
Alzheimers Dement. 2025;21:e70239.
- TOROK J, Mezias C, Raj A
Directionality bias underpins divergent spatiotemporal progression of
Alzheimer-related tauopathy in mouse models.
Alzheimers Dement. 2025;21:e70092.
- DOS REIS RG, Singulani MP, Forlenza OV, Gattaz WF, et al
Kynurenine pathway metabolite alterations in Down syndrome and Alzheimer's
disease.
Alzheimers Dement. 2025;21:e70197.
- SHARON O, Zhelezniakov V, Gat Y, Falach R, et al
Slow wave synchrony during NREM sleep tracks cognitive impairment in prodromal
Alzheimer's disease.
Alzheimers Dement. 2025;21:e70247.
- TIAN X, Zhu M, Ma Y, Wang N, et al
Physical and biopsychosocial frailty, cognitive phenotypes, and plasma biomarkers
for Alzheimer's disease in Chinese older adults: A population-based study.
Alzheimers Dement. 2025;21:e70303.
- ASHTON NJ, Benedet AL, Molfetta GD, Pola I, et al
Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic
Acid Linked Immuno-Sandwich Assay.
Alzheimers Dement. 2025;21:e14621.
- RODDA J, Kuchenbecker LA, Borelli WV, DeMarco ML, et al
Global multi-specialty clinician perspectives on the implementation of
Alzheimer's disease blood biomarkers.
Alzheimers Dement. 2025;21:e70201.
- LIN F
Comment on "Independent associations of high-density lipoprotein cholesterol and
triglyceride levels with Alzheimer's disease and related dementias".
Alzheimers Dement. 2025;21:e70233.
- COHEN AD, Villemagne VL
A brief history of Abeta imaging.
Alzheimers Dement. 2025;21:e70291.
- ZUELSDORFF M, Abner EL, Balls-Berry JE, Jicha GA, et al
Introducing social determinants of health to the Alzheimer's Disease Research
Center network: Development and implementation in the Uniform Data Set.
Alzheimers Dement. 2025;21:e70279.
- LEUNG YY, Lee WP, Kuzma AB, Nicaretta H, et al
Alzheimer's Disease Sequencing Project release 4 whole genome sequencing dataset.
Alzheimers Dement. 2025;21:e70237.
- LI OY, Shin S, Zhou S, Turnbull A, et al
Relationships between neuropsychiatric symptoms, subtypes of astrocyte
activities, and brain pathologies in Alzheimer's disease and Parkinson's disease.
Alzheimers Dement. 2025;21:e70242.
- CUI L, Zhang Z, Huang CC, Yuan CY, et al
Beyond binary classification: Comparing three region-based multi-phase Abeta staging
systems.
Alzheimers Dement. 2025;21:e70253.
- MCHUGH CP, Clement MHS, Phatak M
AD Workbench: Transforming Alzheimer's research with secure, global, and
collaborative data sharing and analysis.
Alzheimers Dement. 2025;21:e70278.
- ZHU X, Xie Y
Comment on "Glycated hemoglobin and body mass index as mediators of GLP-1RAs and
Alzheimer's disease and related dementias in patients with type 2 diabetes".
Alzheimers Dement. 2025;21:e70295.
-
Correction to "Resistance and resilience to Alzheimer's disease in Down
syndrome".
Alzheimers Dement. 2025;21:e70302.
- LIN Y, Shi X, Mu J, Ren H, et al
Uncovering stage-specific neural and molecular progression in Alzheimer's
disease: Implications for early screening.
Alzheimers Dement. 2025;21:e70182.
- BUCHHOLZ S, Kabbani MAA, Bell-Simons M, Kluge L, et al
The tau isoform 1N4R confers vulnerability of MAPT knockout human iPSC-derived
neurons to amyloid beta and phosphorylated tau-induced neuronal dysfunction.
Alzheimers Dement. 2025;21:e14403.
Am J Geriatr Psychiatry
- TALMASOV D, Johnson AS, Brown PJ, Provenzano FA, et al
Depressive Symptoms Correlate With Tau Accumulation Rates in Amyloid Positive
Adults.
Am J Geriatr Psychiatry. 2025;33:756-769.
Biol Psychiatry
- PARK JI, Lee S, Huber B, Devanand DP, et al
Empirical Classification of Neuropsychiatric Symptoms and Association of Classes
With Diagnostic Progression and Cognitive Decline in Mild Cognitive Impairment
and Alzheimer's Disease Populations.
Biol Psychiatry. 2025;97:1059-1066.
- WANG Q, Qi S, Jiang R, Sui J, et al
Unlocking Alzheimer's Disease Heterogeneity: The Role of Normative Modeling,
Dynamic Connectivity, and Beyond.
Biol Psychiatry. 2025;97:1016-1017.
- VASILEIADI M, Nestor SM
From Brain Network Dysfunction to Neuropsychiatric Symptoms in Alzheimer's
Disease.
Biol Psychiatry. 2025;97:1020-1021.
Brain Res
- SALGADO KDCB, Nascimento RGF, Albuquerque ALS, Oliveira LAM, et al
Melatonin protects mouse hippocampal neurons from neurotoxicity induced by
amyloid beta-peptide(25-35).
Brain Res. 2025;1859:149637.
- SOLEIMANI Z, Davoudi S, Saffarzadeh F, Behzadi G, et al
Restoring neuronal excitability and spatial memory through inhibiting
amyloid-beta-induced hyperactive NF-kappaB in a rat model of Alzheimer's disease.
Brain Res. 2025;1861:149703.
Curr Alzheimer Res
- KARADURAN K, Aydogdu A, Gelisin O, Gunpinar S, et al
Predictive Value of Complete Blood Count Parameters for Alzheimer's Disease in
Relation to Periodontal Status.
Curr Alzheimer Res. 2025 May 19. doi: 10.2174/0115672050388220250511174043.
Exp Gerontol
- HAKHU S, Hooyman A, Lingo VanGilder J, Schaefer SY, et al
Association between diffusion MRI-based measures of neurite microstructure and
risk of Alzheimer's disease.
Exp Gerontol. 2025;206:112782.
J Alzheimers Dis
- SACU S, Slattery CF, Friston KJ, Paterson RW, et al
Neural mechanisms of disease pathology and cognition in young-onset Alzheimer's
disease variants.
J Alzheimers Dis. 2025 May 22:13872877251344325. doi: 10.1177/13872877251344325.
- PANDEY JP, Kimball C, Nietert PJ
Epistatic effects of immunoglobulin KM (kappa marker) allotypes and APOE epsilon4 allele on
the risk of Alzheimer's disease.
J Alzheimers Dis. 2025 May 22:13872877251343315. doi: 10.1177/13872877251343315.
- LIU H, Li Y, Sun Z, Xu X, et al
Altered hemispheres lateralization of brain functional gradients in Alzheimer's
disease.
J Alzheimers Dis. 2025 May 22:13872877251339761. doi: 10.1177/13872877251339761.
- COOPER JK
Differences between East and West may affect dementia studies: Thoughts from the
KSA dementia prevalence study.
J Alzheimers Dis. 2025;105:368-369.
- BARTOLINI E, Di Crosta A, La Malva P, Marin A, et al
Gamma oscillation modulation for cognitive impairment: A systematic review.
J Alzheimers Dis. 2025;105:331-350.
- ZHAI Y, Lu K, Yuan Y, Zhang Z, et al
Semaglutide improves cognitive function and neuroinflammation in APP/PS1
transgenic mice by activating AMPK and inhibiting TLR4/NF-kappaB pathway.
J Alzheimers Dis. 2025;105:416-432.
- LABONTE J, Sugarman MA, Pettway E, Zetterberg H, et al
Sex differences on tau, astrocytic, and neurodegenerative plasma biomarkers.
J Alzheimers Dis. 2025;105:443-452.
- NONG Y, Kim JS, Jia L, Arancio O, et al
The interaction between neurotransmitter receptor activity and amyloid-beta
pathology in Alzheimer's disease.
J Alzheimers Dis. 2025 May 19:13872877251342273. doi: 10.1177/13872877251342273.
- LANDRY A, Elsliger S, Gaudet J, Al-Shamaa S, et al
Psychological impact of biomarker-assisted diagnosis of Alzheimer's disease.
J Alzheimers Dis. 2025 May 21:13872877251341587. doi: 10.1177/13872877251341587.
- MIYASHITA A, Obinata A, Hara N, Mitsumori R, et al
Association of rare APOE missense variants with Alzheimer's disease in the
Japanese population.
J Alzheimers Dis. 2025 May 21:13872877251340710. doi: 10.1177/13872877251340710.
- LI Y, Yao YL, Wu Y
Causal relationships between plasma proteins and Alzheimer's disease using
bidirectional Mendelian randomization.
J Alzheimers Dis. 2025 May 21:13872877251345151. doi: 10.1177/13872877251345151.
- ISHIMARU D, Satake Y, Kanemoto H, Taomoto D, et al
Thieves in the delusions of theft in patients with Alzheimer's disease living
alone: A case series.
J Alzheimers Dis. 2025 May 21:13872877251343313. doi: 10.1177/13872877251343313.
- MENG X, Gong Y, Xiao F, Cao Z, et al
Curcumin's multi-target mechanisms in the treatment of Alzheimer's disease and
creative modification techniques.
J Alzheimers Dis. 2025 May 21:13872877251344188. doi: 10.1177/13872877251344188.
J Am Geriatr Soc
- RYDBERG MG
A cross-sectional analysis of open payments from pharmaceutical companies to
memory center physicians.
J Am Geriatr Soc. 2025;73:1528-1534.
- HARRISON KL, Morgan BE, Friend J, Garrett SB, et al
"By the Time We Knew ...": Poetic Analysis of End-of-Life Caregiving Experiences
for Rapidly Progressive and Slower-Duration Dementia Syndromes.
J Am Geriatr Soc. 2025;73:1406-1418.
Lancet
- FORTEA J, Boban M, Engelborghs S, Frederiksen KS, et al
Regulatory asymmetry in Alzheimer's disease care.
Lancet. 2025 May 14:S0140-6736(25)00907-9. doi: 10.1016/S0140-6736(25)00907.
Neurobiol Dis
- ZARE MS, Abedpoor N, Hajibabaie F, Walker AK, et al
Gene co-expression patterns shared between chemobrain and neurodegenerative
disease models in rodents.
Neurobiol Dis. 2025;211:106944.
- SPENCER B, Schueler A, Sung D, Rissman RA, et al
Differential roles of human tau isoforms in the modulation of inflammation and
development of neuropathology.
Neurobiol Dis. 2025;211:106942.
Neuropsychology
- LOPEZ-MARTOS D, Brugulat-Serrat A, Suarez-Calvet M, Mila-Aloma M, et al
Robust longitudinal neuropsychological norms in Spanish individuals with
nonpathological Alzheimer's disease biomarkers.
Neuropsychology. 2025 May 22. doi: 10.1037/neu0001013.
PLoS One
- JIANG H, Chen Z, Liu Y, Yang C, et al
The structure of spontaneous speech changes in Alzheimer's disease: Crosslingual
evidence from English and Greek.
PLoS One. 2025;20:e0324270.
- KHEDRAOUI M, Karim EM, Abchir O, Errougui A, et al
2D-QSAR-guided design of potent carbamate-based inhibitors of
acetylcholinesterase.
PLoS One. 2025;20:e0320789.
- HENNEY MA, Hansen BL, Hansen LS, Gronberg MG, et al
Re-evaluating the choice of gamma stimulation frequency for the potential
treatment of Alzheimer's disease: Novel invisible spectral flicker evokes gamma
responses at various frequencies.
PLoS One. 2025;20:e0321633.
Proc Natl Acad Sci U S A
-
Correction for Masliah et al., beta-Amyloid peptides enhance alpha-synuclein
accumulation and neuronal deficits in a transgenic mouse model linking
Alzheimer's disease and Parkinson's disease.
Proc Natl Acad Sci U S A. 2025;122:e2509530122.
- KOH Y, Vazquez-Rosa E, Gao F, Li H, et al
Inhibiting 15-PGDH blocks blood-brain barrier deterioration and protects mice
from Alzheimer's disease and traumatic brain injury.
Proc Natl Acad Sci U S A. 2025;122:e2417224122.
- CHEN W, Liu X, Munoz VR, Kahn CR, et al
Loss of insulin signaling in microglia impairs cellular uptake of Abeta and
neuroinflammatory response exacerbating AD-like neuropathology.
Proc Natl Acad Sci U S A. 2025;122:e2501527122.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016